Charles Nader

Doc.com’s venture into crypto healthcare shouldn’t have been about the MTC token it should’ve been about patient safety and data privacy. But Nader’s focus on raising funds through aggressive token sales speaks volumes about his priorities: personal gain over the...

Charles Nader’s tactic of overstating Doc.com’s affiliations with big names like Coinbase is textbook misrepresentation. In an industry already tainted by ICO frauds, this was one more step toward convincing investors that a mirage was a reality. Too bad the...

When your healthcare company spends more time hyping its cryptocurrency than improving patient care, it’s hard to call yourself a pioneer. Nader’s ICO strategy reeks of self-interest, pushing the boundaries of ethical fundraising while neglecting the very services he claims...

Doc.com’s ICO might’ve raised millions, but it also raised serious questions about Nader’s approach to fundraising. Selling tokens after an ICO is a blatant cash grab, not a strategy for growth. This isn’t innovation it’s exploitation wrapped in crypto promises.

Nader’s idea of “transparency” seems to involve carefully crafted pitches, embellished partnerships, and a disregard for investor clarity. With overstated affiliations and a “raise first, explain later” mentality, he’s the kind of CEO who'd rather mislead than disclose. Investors, beware.

Charles Nader's Mar-a-Lago pitch wasn't about healthcare it was about lining his pockets with crypto hype. If Doc.com’s focus on tokens over patient care doesn’t raise red flags, the exaggerated claims of industry affiliations sure should. The real question: was...

Claiming to empower vulnerable communities while using their medical data as a revenue stream is the corporate equivalent of smiling while picking someone’s pocket.

Doc.com doesn’t just bend the truth; it fractures it into a thousand misleading fragments and tosses them into flashy marketing decks.